AJP - Heart Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (December 12, 2008). doi:10.1152/ajpheart.01105.2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
296/2/H505    most recent
01105.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huang, B. P.-H.
Right arrow Articles by Proud, C. G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huang, B. P.-H.
Right arrow Articles by Proud, C. G
Submitted on October 18, 2008
Revised on December 8, 2008
Accepted on December 8, 2008

Blocking eukaryotic initiation factor (eIF) 4F complex formation does not inhibit the mTORC1-dependent activation of protein synthesis in cardiomyocytes

Brandon Pei-Han Huang1, Yanni Wang1, Xuemin Wang2, Zhuren Wang3, and Christopher G Proud4*

1 UBC
2 University of Southampton
3 University of British Columbia
4 School of Biological Sciences

* To whom correspondence should be addressed. E-mail: C.G.Proud{at}soton.ac.uk.

Activation of mammalian target of rapamycin complex 1 (mTORC1) causes the dissociation of 4E-BP1 from eIF4E leading to increased eIF4F complex formation. mTORC1 positively regulates protein synthesis and is implicated in several diseases including cardiac hypertrophy, a potentially fatal disorder involving increased cardiomyocyte size. The importance of 4E-BP1 in mTORC1-regulated protein synthesis was investigated by overexpressing 4E-BP1, which blocks eIF4F formation in isolated primary cardiomyocytes without affecting other targets for mTORC1 signaling. Interestingly, blocking eIF4F formation did not impair the degree of activation of overall protein synthesis by the hypertrophic agent phenylephrine (PE) which, furthermore, remained dependent on mTORC1. Overexpressing 4E-BP1 also only had a small effect on PE-induced cardiomyocyte growth. Overexpressing 4E-BP1 did diminish the PE-stimulated synthesis of luciferase encoded by 'structured' mRNAs, confirming that such mRNAs do require eIF4F for their translation in cardiomyocytes. These data imply that the substantial inhibition of cardiomyocyte protein synthesis and growth caused by inhibiting mTORC1 cannot be attributed to activation of 4E-BP1 or loss of eIF4F complexes. Our data indicate that increased eIF4F formation plays, at most, only a minor role in the mTORC1-dependent activation of overall protein synthesis in these primary cells but is required for the translation of structured mRNAs. Other mTORC1 targets are therefore more important in the inhibition by rapamycin of the rapid activation of protein synthesis and of cell growth.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.